ArticleClinical and translational gastroenterology2026
Dietary Factors Associated With the Progression of Gastric Intestinal Metaplasia: A Multicenter, Prospective Cohort Study in a Western Population.
Article in Clinical and translational gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionAlthough several dietary factors such as high salt intake are linked to progression of gastric intestinal metaplasia (GIM) to gastric cancer (GC) in high-risk countries, their effect on GIM progression in Western populations remains less clear. This study investigates the influence of dietary factors on GIM progression in a Western population.
methodsThe PROgression and REgression of precancerous GAstric Lesions (PRORGAL) study (2009-2024) is a prospective cohort study of GIM patients undergoing surveillance. The operative link on GIM criteria determined GIM stage, with an increase in operative link on GIM stage reflecting disease progression. Data on family history, medication use, and diet were collected through self-reported questionnaire and by medical records. Multivariate logistic regression was used to identify risk factors of disease progression.
resultsA total of 312 GIM patients were included (median age 61 years, 50.3% men, median follow-up 54 months, IQR 36). Progression occurred in 112 patients (35.9%), with 6 patients (1.9%) developing high-grade dysplasia or GC. High dietary salt consumption (OR 1.67; 95% CI 1.05-2.68, P = 0.04), meat ≥6 servings per week (OR 1.25; 95% CI 1.07-1.46, P = 0.004) smoking (OR 1.76; 95% CI 1.04-2.68), autoimmune gastritis (OR 2.49; 95%CI 1.04-5.83) and having a positive first-degree family member with GC (OR 2.01; 95%CI 1.20-3.52) were significantly associated with GIM progression. Fish consumption, alcohol intake, and previous Helicobater pylori infection showed no significant association with GIM progression. DISCUSSION: Increased consumption of meat and salt is significantly associated with GIM progression, suggesting that dietary risk factors of GIM progression are similar in low-incidence and high-incidence countries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.